CrossrefInfokarte
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial
American Journal of Stem Cells · 2025 · 14 (4) · 244-260
DOI: 10.62347/ophf7871 ↗Abstract
Kein Abstract verfügbar.
EUVIMED